BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10964330)

  • 1. Suppression of proline-directed protein kinase F(A) expression potentiates erythroid differentiation of human myeloid leukemia cells.
    Hsu CP; Yang CC; Yang SD
    Cancer; 2000 Sep; 89(5):1004-11. PubMed ID: 10964330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense suppression of proline-directed protein kinase FA enhances chemosensitivity in human prostate cancer cells.
    Yang CC; Hsu CP; Yang SD
    Clin Cancer Res; 2000 Mar; 6(3):1024-30. PubMed ID: 10741730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of proline-directed protein kinase F(A) expression inhibits the growth of human chronic myeloid leukaemia cells.
    Hsu CP; Hsueh SF; Yang CC; Yang SD
    Br J Cancer; 2000 Apr; 82(8):1480-4. PubMed ID: 10780530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of proline-directed protein kinase FA with tumorigenesis, invasion, and poor prognosis of human colon carcinoma.
    Chung YC; Chang KJ; Yang CC; Lai MT; Hsu CP; Hsueh SF; Peng CC; Fu HH; Chang YF; Yang SD
    Cancer; 2002 Nov; 95(9):1840-7. PubMed ID: 12404276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of proline-directed protein kinase F(A) inhibits the malignant growth of human pancreatic ductal adenocarcinoma.
    Fu HH; Yang SD
    Anticancer Res; 2004; 24(3a):1489-94. PubMed ID: 15274314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of overexpressed proline-directed protein kinase F(A) with chemoresistance, invasion, and recurrence in patients with bladder carcinoma.
    Hsueh SF; Lai MT; Yang CC; Chung YC; Hsu CP; Peng CC; Fu HH; Cheng YM; Chang KJ; Yang SD
    Cancer; 2002 Aug; 95(4):775-83. PubMed ID: 12209721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of proline-directed protein kinase F(A) systemically inhibits the growth of human acute leukemia cells.
    Hsu CP; Yang CC; Yang SD
    Int J Cancer; 2001 Mar; 91(5):650-53. PubMed ID: 11267978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proline-directed protein kinase FA as a new signal transducing target for lethal cancer treatment.
    Yang SD
    Drug News Perspect; 2005 Sep; 18(7):432-6. PubMed ID: 16362082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
    Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD
    J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of proline-directed protein kinase F(A) potentiates apoptotic induction and greatly enhances chemosensitivity in human acute lymphoblastic leukemia cells.
    Hsu CP; Yang CC; Hsueh SF; Peng CC; Fu HH; Yang SD
    Cancer; 2001 Oct; 92(7):1753-8. PubMed ID: 11745246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
    Woessmann W; Zwanzger D; Borkhardt A
    Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells.
    Rizzi M; Tschan MP; Britschgi C; Britschgi A; Hügli B; Grob TJ; Leupin N; Mueller BU; Simon HU; Ziemiecki A; Torbett BE; Fey MF; Tobler A
    J Leukoc Biol; 2007 Jun; 81(6):1599-608. PubMed ID: 17347302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disialoganglioside GD3 synthase expression recruits membrane transglutaminase 2 during erythroid differentiation of the human chronic myelogenous leukemia K562 cells.
    Kang SK; Kim YS; Kong YJ; Song KH; Chang YC; Park YG; Ko JH; Lee YC; Kim CH
    Proteomics; 2008 Aug; 8(16):3317-28. PubMed ID: 18690648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W; Mivechi NF
    Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new 2-aminosteroid induces cellular differentiation and upregulates the expression of MafB and Egr-1 genes respectively in HL-60 and K562 leukemia cells.
    He Q; Li Q; Yuan LB; He J
    Chin Med J (Engl); 2005 Jan; 118(2):91-9. PubMed ID: 15667792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
    Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X
    Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line.
    Francastel C; Groisman R; Pfarr CM; Robert-Lézénès J
    Oncogene; 1994 Jul; 9(7):1957-64. PubMed ID: 8208542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cellular activity and protein level of protein kinase FA/GSK-3 alpha correlates with human thyroid tumor cell dedifferentiation.
    Lee TT; Ho YS; Yu JS; Yang SD
    J Cell Biochem; 1995 Aug; 58(4):474-80. PubMed ID: 7593269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of hemin-induced gene expression in K562 cells].
    Chen HC; Meng Q
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):185-9. PubMed ID: 12864948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.